Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT – Get Free Report) saw a large decrease in short interest in June. As of June 30th, there was short interest totalling 8,700 shares, a decrease of 28.7% from the June 15th total of 12,200 shares. Based on an average trading volume of 20,700 shares, the short-interest ratio is presently […]
Lixte Biotechnology (NASDAQ:LIXT – Get Rating) is one of 941 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare Lixte Biotechnology to similar businesses based on the strength of its profitability, earnings, dividends, institutional ownership, valuation, analyst recommendations and risk. Insider and Institutional Ownership 8.8% of […]
Lixte Biotechnology (NASDAQ:LIXT – Get Rating) is one of 941 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its peers? We will compare Lixte Biotechnology to related companies based on the strength of its institutional ownership, valuation, earnings, analyst recommendations, dividends, risk and profitability. Analyst Ratings This is […]
Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT – Get Rating) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 15,500 shares, a decline of 59.2% from the February 28th total of 38,000 shares. Currently, 0.3% of the shares of the company are […]